Rating: SELL
SELL (5-tier) · mature cash generator · conviction: medium
| Metric | Value |
|---|---|
| Current Price | $255 |
| Triangulated Fair Value | $223 (-13% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $219 (-14% vs spot · 12m PWEV) |
| Forward P/E | 18.6x |
| Market Cap | $63B |
| 52-Week Range | $190–$320 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Investment Committee Summary
| Rating | SELL · SELL (5-tier) |
| Classification · conviction | mature cash generator · medium |
| Triangulated fair value | $223 (-13% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $219 (-14% vs spot · 12m PWEV) |
| Next catalyst | 2026-07-30 — Quarterly earnings |
| Primary thesis-break | Brokerage organic revenue growth (reported quarterly) < 4.0% (2 consecutive prints) |
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Rating Bridge
Rating = SELL because:
- Probability-weighted scenario value implies -14% vs spot
- Monte Carlo median implies -22% vs spot
- DCF fair value implies -5% vs spot — but this is terminal-value sensitive (exit-multiple $242 vs Gordon $300, 24% apart), so it carries less weight
- Bear case (Structural — Soft-Market / Commission Pressure) downside is -56% vs spot
- Net: reward/risk of 0.2× warrants a Sell.
Investment Thesis
At $229.57 (2026-06-27) AJG trades on 16.8x forward earnings against a broker-peer median of 14.7x. The market is paying a premium for a fee-based compounder: 7% growth, a 29% segment margin and a tuck-in machine that recycles capital at accretive multiples, with no underwriting risk. The engine agrees with the business quality but not the price. The probability-weighted target is $219.20, 4.5% below spot, and the Monte Carlo puts only a 32.9% probability on fair value above the current price. The drag is concentrated: 72% of simulation variance sits in the multiple, and a 20%-weighted structural soft-market scenario resolves to $111.44, well under the $190.12 52-week low. The DCF at $242.37 offers modest support but cannot offset that left tail. HOLD follows: the premium is earned, yet fully paid. The single most damaging risk is a P&C soft market compressing commissions and the premium multiple simultaneously.
The dashboard below is the whole argument on one page: spot ($255) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural bear case is mechanical, not speculative. Commissions are ad valorem: after several years of hard-market pricing, composite P&C rates roll negative and AJG's revenue base shrinks with no loss of clients. Compensation is sticky, so margin de-leverages from 29% toward 24% while fiduciary interest income fades with rates. The tuck-in arbitrage narrows at the same time, because seller multiples stay firm while AJG's own currency de-rates from 16.8x toward 10-11x, as the market reprices a cyclical revenue stream it had valued as a secular compounder. Earnings and the multiple compress together, and the $15.9B FY2025 investing outflow for AssuredPartners leaves less balance-sheet room to buy through the trough. That path lands near $111, beneath the 52-week low.
Key Debate
P/E Multiple explains 72% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.63 vs analyst floor +0.00 → delta +0.63 (n=27 mgmt / 18 Q&A; 92th pctile across the S&P book, z +1.4).
Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.63 | +0.00 | +0.63 |
| 2025Q4 | +0.54 | +0.12 | +0.42 |
| 2025Q3 | +0.34 | +0.00 | +0.34 |
| 2025Q2 | +0.32 | +0.03 | +0.29 |
News (last 365d, 1000 articles): avg ticker sentiment +0.06 (bullish 13% / bearish 14%)
Scenario Analysis
The tree runs from a structural 'Structural — Soft-Market / Commission Pressure' downside ($112) to a 'Bull — Defensive Re-Rate' bull case ($343); the probability-weighted blend (PWEV $219) is -14% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Soft-Market / Commission Pressure | 20% | $112 | -56% |
| Economic / Exposure Recession | 17% | $180 | -29% |
| Base — Organic + Pricing + M&A | 35% | $230 | -10% |
| Growth — Specialty / International / Consolidation | 20% | $290 | +14% |
| Bull — Defensive Re-Rate | 8% | $343 | +35% |
| Probability-Weighted (PWEV) | — | $219 | -14% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Soft-Market / Commission Pressure (20%, $112). Structural impairment — soft-market / commission pressure: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 111.44; probability: 0.2.
- Economic / Exposure Recession (17%, $180). Cyclical downturn — brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk) weakens for 1–2 years before normalising. Drivers — implied_target: 180.26; probability: 0.17.
- Base — Organic + Pricing + M&A (35%, $230). Mid-cycle — normalised brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk); disciplined capital allocation; steady returns. Drivers — implied_target: 230.51; probability: 0.35.
- Growth — Specialty / International / Consolidation (20%, $290). Upside — specialty / international / consolidation lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 291.04; probability: 0.2.
- Bull — Defensive Re-Rate (8%, $343). Upside tail — sustained tight conditions or a structural re-rate on specialty / international / consolidation. Drivers — implied_target: 342.3; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $197 | -22% |
| Peer P/E re-rate | multiple | $202 | -21% |
| Peer EV/Revenue re-rate | multiple | $230 | -10% |
| Scenario PWEV | multiple | $219 | -14% |
| DCF (5-year + terminal) | cash flow + terminal × | $242 | -5% |
| Triangulated (weighted) | — | $223 | -13% |
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $197 and 22% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (72% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 8.0%, 14x terminal FCF multiple → $242. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 14.73x) implies $202. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is 20% of the median — moderate (healthy method disagreement — read the blend with care).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Insurance Brokerage | $14.2B | 100% | 7% | 29% | $4.1B | 16x | 2% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk) |
| net_debt_or_cash_b | 0.27 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.02 |
| div_yield | 0.012 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | soft-market / commission pressure |
| upside | specialty / international / consolidation |
Industry Context — Financials — Insurance Services
This name sits in the Financials — Insurance Services as a insurance_broker. brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk) Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: MRSH (insurance_broker) · AON (insurance_broker) · AJG (insurance_broker) · WTW (insurance_broker) · BRO (insurance_broker) · ERIE (insurance_broker)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Soft-Market / Commission Pressure | 37% | 37% | |
| Mid-Cycle — Organic + Pricing + M&A | 35% | 35% | |
| Upside — Specialty / Consolidation | 28% | 28% |
Mapping note: name-level 'Structural — Soft-Market / Commission Pressure' (20%) + 'Economic / Exposure Recession' (17%) map to cluster Soft-Market / Commission Pressure (37%); name-level 'Growth — Specialty / International / Consolidation' (20%) + 'Bull — Defensive Re-Rate' (8%) map to cluster Upside — Specialty / Consolidation (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Soft-Market / Commission Pressure () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The fin_insurance_services cycle is the shared macro driver. Driver — brokerage organic growth + P&C pricing cycle + bolt-on M&A (no underwriting risk) Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $15B | $5B | $0B | $0B | $4B | $3B |
| FY+2 | $16B | $5B | $0B | $0B | $4B | $3B |
| FY+3 | $17B | $5B | $0B | $0B | $4B | $3B |
| FY+4 | $18B | $6B | $0B | $0B | $4B | $3B |
| FY+5 | $19B | $6B | $0B | $0B | $5B | $3B |
| Terminal | — | — | — | — | $5B × 14x | $44B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 2% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 8.0% · Σ PV(FCF) $16B + PV(terminal) $44B = EV $60B; + net cash → equity $60B ÷ diluted shares 0.25B = $242/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $300/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 120% vs WACC 8% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| MRSH | 3.598x | 15.67x | 7% | 24% |
| AON | 4.779x | 17.15x | 7% | 36% |
| WTW | 3.006x | 13.79x | 7% | 20% |
| BRO | 4.422x | 13.26x | 7% | 47% |
| Median | 4.01x | 14.73x | — | — |
Peer-median fwd P/E → $202; EV/Rev → $230.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $242 | 41% | $100 |
| Scenario PWEV | $219 | 29% | $64 |
| Monte Carlo median | $197 | 18% | $35 |
| Peer P/E | $202 | 12% | $24 |
| Triangulated | — | 100% | $223 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 9.8x | 11.9x | 14.0x | 16.1x | 18.2x |
|---|---|---|---|---|---|
| 6% | $205 | $234 | $263 | $292 | $321 |
| 7% | $197 | $225 | $252 | $280 | $308 |
| 8% | $189 | $216 | $242 | $268 | $295 |
| 9% | $182 | $207 | $232 | $258 | $283 |
| 10% | $175 | $199 | $223 | $247 | $271 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $193 | $203 | $213 | $223 | $233 |
| -1.5pp | $206 | $216 | $227 | $238 | $249 |
| +0.0pp | $219 | $231 | $242 | $254 | $265 |
| +1.5pp | $233 | $246 | $258 | $270 | $282 |
| +3.0pp | $248 | $261 | $274 | $287 | $300 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Revenue CAGR ±3pp | $213 | $274 | $61 |
| Terminal × ±15% | $216 | $268 | $53 |
| Op margin ±3pp | $219 | $265 | $46 |
| WACC ±1pp | $232 | $252 | $20 |
| Capex intensity ±15% | $240 | $244 | $3 |
Company lever — SoP/share vs Insurance Brokerage multiple (AI re-rating) (base 16x)
| Multiple | 11.2x | 13.6x | 16.0x | 18.4x | 20.8x |
|---|---|---|---|---|---|
| SoP/share | $642 | $780 | $917 | $1,055 | $1,192 |
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $266 (+5% vs spot · street) |
| House target | $219 (-17.7% vs street) |
| Sell-side coverage | 22 analysts (SB 4 / B 13 / H 5 / S 0 / SS 0; net score 0.48) |
| Consensus FY EPS | $14.87; house below (-7.9%) |
| Consensus FY revenue | $18.3B; house below (-17.1%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $12.6B — highly levered |
| Net debt / EBITDA | 3.18x |
| Interest coverage (EBIT / interest) | 4.0x |
| Current ratio | 1.06x |
| Lease obligations | $0.5B |
| Cash & ST investments | $1.4B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $1.8B |
| Buybacks / dividends | $1.5B / $0.7B |
| Total shareholder yield | 3.4% |
| Payout as % of FCF | 121.3% |
| Reinvestment (capex / OCF) | 7.5% |
| SBC as % of FCF | 2.7% |
| Allocation stance | returning more than FCF (balance-sheet funded) |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 12.6% |
| FCF conversion (FCF / net income) | 119.5% |
| FCF yield | 2.8% |
| Capex intensity (capex / revenue) | 1.0% |
| FCF − SBC (diagnostic) | $1.7B |
| Capex split (maint / growth) | 90% / 10% — Asset-light intermediary; physical capex is minimal (office/IT). Real capital deployment is M&A, which sits below the capex line. The maintenance-heavy split reflects a fee-based compounder, not a builder. |
Accounting quality: SBC 0.3% of revenue; cash conversion (OCF/NI) 129% — cash-backed.
Catalyst Calendar
- 2026-07-30 (~22d) — Quarterly earnings — est. EPS $2.86 (AV EARNINGS_CALENDAR)
- 2026-09-15 (~69d) — Investor day / long-term organic-growth and margin targets (authored)
- 2026-10-01 (~85d) — January 1 reinsurance renewal season pricing (Gallagher Re) (authored)
- 2027-01-15 (~191d) — AssuredPartners / large-deal integration milestone (authored)
Forecast Track Record
- EPS surprise: beat 62.5% of the last 8 quarters; average surprise +0.0%.
Competitive Moat
Wide moat. Gallagher's moat is wide: a fee/commission brokerage with ~90%+ client retention, scale in specialty and reinsurance broking, and a decades-proven tuck-in M&A machine that recycles capital at accretive multiples with no underwriting balance-sheet risk. A wide, capital-light compounder justifies a premium terminal multiple above the market - the ~17x forward P/E holds while organic growth stays mid-single-digit and M&A stays accretive; it should compress toward the broker-peer ~14-15x only if organic growth falls below ~4% or acquisition multiples paid exceed value created - falsified if organic + M&A growth sustains double-digit EPS compounding.
Moat sources:
- ~90%+ client retention and recurring commission/fee revenue
- Scale and data advantage in specialty and reinsurance broking (Gallagher Re)
- Proven serial tuck-in M&A engine with a disciplined integration playbook
- No underwriting risk - pure intermediary economics with high incremental margins
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Broker compensation / contingent-commission transparency and conflict-of-interest scrutiny | medium (~40%) | medium - contingent commissions are high-margin; disclosure or curbs could clip ~4-6% of FV | 12-24m |
| Antitrust / integration review on large brokerage acquisitions | low (~25%) | low - slows the M&A engine at the margin rather than impairing the base, ~2% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Soft-Market / Commission Pressure | A prolonged soft P&C market cuts premium rates, shrinking commission per placement while contingent commissions compress and the M&A pipeline dries up. | Organic growth falling below ~4% permanently, removing the compounding that justifies the premium multiple and triggering de-rating. |
| Economic / Exposure Recession | A broad economic downturn reduces insurable exposures (payrolls, revenues, fleets), lowering the base on which commissions are earned. | Exposure-driven revenue decline compounding with client attrition in a recession, hitting the recurring-revenue assumption. |
| Base — Organic + Pricing + M&A | Mid-single-digit organic growth, modest P&C rate firming, and continued accretive tuck-in M&A at historical multiples. | Acquisition multiples paid creeping up faster than synergies delivered, quietly eroding return on invested capital. |
| Growth — Specialty / International / Consolidation | Accelerated specialty and international share gains plus consolidation of a fragmented mid-market drive double-digit revenue compounding. | Integration strain and cultural dilution from an elevated deal pace degrading the retention that underpins the moat. |
| Bull — Defensive Re-Rate | In a risk-off tape, the market rewards AJG's fee-based, recession-resilient cash flows with a further multiple premium. | A defensive re-rate is a tape-driven, not fundamentals-driven, gain and reverses when risk appetite returns. |
What the Market Is Pricing In
At the current price, the market pays 17.1× forward EPS, vs the house DCF terminal 14.0×, and a peer median 14.73×. The house DCF sits 5% below spot, so the market is pricing in more than the house case — roughly 0.6pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 18.3 | 15.2 | High |
| EPS | 14.9 | 13.7 | Medium |
| Target price | 266.4 | 219.2 | Medium |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| MRSH | 15.67× | 7% | 24% | direct | 100% |
| AON | 17.15× | 7% | 36% | direct | 100% |
| WTW | 13.79× | 7% | 20% | segment | 50% |
| BRO | 13.26× | 7% | 47% | segment | 50% |
Quality-weighted forward P/E: 15.4× (simple median 14.73×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $190–$320, centre $246 (-3% vs spot); spot sits at the 50th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $223 (-13% vs spot · triangulated FV) |
| Downside to bear case (Structural — Soft-Market / Commission Pressure) | $112 (-56% vs spot · bear scenario) |
| Reward/risk ratio | 0.2× |
| Margin of safety (FV vs spot) | -14% |
| P(price > spot) — Monte Carlo | 22% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Defensive Re-Rate): $343.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 8.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 14× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (61.0); Terminal × ±15% (53.0); Op margin ±3pp (46.0); WACC ±1pp (20.0); Capex intensity ±15% (3.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $14.2B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $15.2B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $14.8714 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.249B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $12.604B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 8.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 14× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-07-08 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-06-27 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-07-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-07-08 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-07-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-07-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-07-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-07-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-07-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Load-Bearing Assumptions
DCF: WACC 8%, terminal multiple 14×, FY+5 revenue $19B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Brokerage organic revenue growth (reported quarterly) < 4.0% (2 consecutive prints → Soft-Market / Commission Pressure). The base path carries 7% segment growth; the recession path 1%. Two prints of organic below the 4% midpoint indicate the P&C pricing tailwind has rolled over and the commission base is decelerating faster than the base path allows.
- Global P&C renewal premium change (Gallagher composite) < 0% (2 consecutive prints → Soft-Market / Commission Pressure). Commissions are ad valorem on premium. A negative composite renewal premium change for two prints is the direct mechanical trigger for the structural soft-market scenario: revenue shrinks on flat client counts and margin de-leverages against a sticky compensation base.
- Brokerage operating margin, engine basis < 28.0% (2 consecutive prints → Soft-Market / Commission Pressure). The base path assumes 29.1% and the recession path 27.0%. Two prints below the 28% midpoint mean compensation and integration costs are absorbing the revenue line faster than the base path tolerates, before any soft market arrives.
- Annualised acquired revenue from completed tuck-in acquisitions (rolling four quarters) < $0.5B (2 consecutive prints → Mid-Cycle — Organic + Pricing + M&A). Bolt-on M&A supplies a material share of the 7% base-path growth. A stalled pipeline for two prints removes that leg and pushes the name toward the organic-only recession path even if pricing holds.
- AssuredPartners integration: goodwill impairment or a cut to stated synergy / accretion guidance > any impairment charge or guidance reduction at a print (single event → Soft-Market / Commission Pressure). FY2025 investing cash outflow of $15.9B reflects the AssuredPartners consummation. An impairment or accretion cut would falsify the assumption that acquired revenue converts at Brokerage-level margins, and would drag the earnings base toward the structural path.
Fact / Inference / Speculation
- FACT: Spot $255; 52-week range $190–$320; engine rating SELL; base-case target $219 (-14%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
- INFERENCE: Triangulated FV $223 (-13% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits above the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Recommendation: SELL
Defensive: rating SELL; triangulated fair value $223 (-13% vs spot) — the risk/reward is skewed to the downside on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.